Bioadaptives, Inc. (BDPT) Net Equity Issued and Repurchased (2022)

Bioadaptives has reported Net Equity Issued and Repurchased for 1 years, with the latest figure at -$1623.0 in Q4 2022.

• Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to -$1623.0 in Q4 2022, while the trailing twelve-month figure through Dec 2024 was -$1623.0 (changed N/A YoY) and the FY2023 annual result came in at $178100.0, changed N/A from the prior year.
• Net Equity Issued and Repurchased steadied at -$1623.0 in Q4 2022 per BDPT's latest filing.
• Over five years, Net Equity Issued and Repurchased peaked at -$1623.0 in Q4 2022 and troughed at -$1623.0 in Q4 2022.